The cancer cell lines being used in the lab to test new compounds keep mutating so that researchers think they are using clones of well-known cancer cell lines. But, because the cells keep mutating, it's adversely affecting tests of efficacy. Arrgh.

http://blogs.sciencemag.org/pipeline/archives...we-thought